ETF · Indices
Strategic CRISPR & Gene Editing Technology Index - Benchmark TR Gross
Total ETFs
1
All Products
1 ETFsName | Asset class | AUM | Durch. Volume | Provider | Expense Ratio | Investment Segment | Index | Launch date | NAV (Net Asset Value) | P/B | P/E |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stocks | 2.1 M | 2,437.82 | KE Kelly | 0.78 | Healthcare | Strategic CRISPR & Gene Editing Technology Index - Benchmark TR Gross | 1/12/2022 | 7.02 | 1.68 | 17.02 |
ETF Directory
ETF DirectoryAll asset classes
All Segments
+109 more